TheProfitWatch

ALGS - Aligos Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.61 0.77 (8.01%) --- --- --- --- 0.77 (8.01%) 0.17 (1.75%) 0.17 (1.75%)

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.53
Diluted EPS:
-1.53
Basic P/E:
-6.7843
Diluted P/E:
-6.7843
RSI(14) 1m:
59.43
VWAP:
10.33
RVol:

Events

Period Kind Movement Occurred At

Related News